Join the real-world data revolution
Our on-demand platform, datasets, and consulting services connect the life sciences industry to patient data from around the globe.
Join the real-world data revolution
Our on-demand platform, datasets, and consulting services connect the life sciences industry to patient data from around the globe.
TriNetX accelerates study design, trial operations, and post-approval research by putting real-world data into the hands of biopharmaceutical companies, study sites, and investigators.
Study Design & Feasibility
Select endpoints, biomarkers, and treatment durations based on real-world data spanning everything from diagnoses to genomic variants. Test criteria against patients receiving care now.
Site Selection & Patient Recruitment
Connect with the care providers in more than 30 countries who supply our data. Invite them to participate in your study and contact pre-qualified patients.
Real-World Evidence Generation
With licensed datasets or analytic tools on our platform, answer questions of safety, efficacy, and value for all your stakeholders, from patients to regulators.
A World of Data
Access continually refreshed, de-identified data from EHR, registries, and claims, integrated and mapped to clear and comprehensive terminology.
Data Linking
Demographics
Diagnoses
Genomics
Lab Results
Longitudinal Patient History
Medications
Mortality
Oncology
Patient Location
Procedures
Provider Notes (NLP)
Tumor Registry
Vitals
Patient Lives
Hospitals, Medical Centers, and Care Networks
Countries
Delivered Your Way
Get answers at the speed of thought by using our on-demand platform, licensing full datasets, or working with our clinical data analysts.
Platform
Build and explore cohorts, compare outcomes, uncover treatment patterns, and more, right on our fast and powerful platform. Our platform is also where’ll you connect with the healthcare organizations who supply our data and stand ready to join your trial.
Datasets
Download datasets that associate every diagnosis, lab result, and other observation to a date and an anonymized patient ID. Run more precise longitudinal analyses by importing this data into your preferred software package.
Consulting
Our Clinical Sciences team represents analysts, epidemiologists, and evidence strategists with decades of experience in every phase and therapeutic area of research. Make this team an extension of your own, for chart reviews, competitive analyses, and more.
Rapid and Powerful Analytics
Quickly gain real-world insights into patients’ baseline characteristics, treatment pathways, and outcomes. Conduct full, protocol-driven observational research studies in a fraction of the usual time.
Hear how sponsors and sites find their advantage with TriNetX
Whether you’re a sponsor looking to evaluate your study’s criteria, or a hospital eager to attract today’s most innovative trials, TriNetX has the data and tools you need. Hear how some of our power users at Sanofi, the Medical University of South Carolina, and the University of Arkansas for Medical Sciences are conducting more, and more informed, research.
News
COVID-19 Research Published in The Lancet Rheumatology Finds Rheumatic Disease Patients are at a Reduced Likelihood of Severe Outcomes Now vs. Early Days of Pandemic
Researchers at Massachusetts General Hospital and Harvard Medical School using de-identified real-world data from TriNetX found decreased risk of hospitalization and death over time for rheumatic disease patients suffering from COVID-19
Scotland’s NHS Greater Glasgow and Clyde Health Board Seeks Better Use of Data and Increased Participation in Clinical Trials by Joining TriNetX Network
NHS Greater Glasgow and Clyde Health Board (NHSGGC), the largest NHS organization in Scotland and one of the largest in the UK, has joined the TriNetX global health research network to better leverage its extensive patient data and to promote its participation in clinical trials and research.
TriNetX Recognized by Deloitte as One of the Fastest-Growing Companies in North America
Cambridge, MA, November 19, 2020 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced it has placed on Deloitte’s Technology Fast 500™, a...
#COVID19 Study Published in @TheLancetRheum by Researchers at @MassGeneralNews and @harvardmed Finds Rheumatic Disease Patients are at a Reduced Likelihood of Severe Outcomes Now vs. Early Days of Pandemic
https://bit.ly/394V0oG
Where there is data, there is hope. From all of us at @TriNetX, we wish you happy holidays, and may the coming year be brighter than the past. https://www.trinetx.com/hope
Welcome @RNOHnhs! We are honored to have you join the #TriNetX global health research network. #clinicalresearch #RWD #RWE
We are really excited @RNOHnhs to be joining @TriNetX. Massive thank you to their team and our local IM&T team in making it happen. https://trinetx.com/
Welcome @NHSGGC to the #TriNetX global health research network. http://bit.ly/2KE6zZZ #realworldata #clinicalresearch #clinicaltrials
“RWD linkage will be particularly valuable for the clinical trials conducted for #COVID19 to support the collection of additional safety and surveillance data,” Medidata, @TriNetX & @DatavantHQ
Read how we joined forces for #RWD pact via @Fiercebiotech: https://bit.ly/3a0an2j
